proteas
sever
acut
respiratori
syndrom
sar
coronaviru
key
enzym
viru
matur
found
first
time
matur
sar
proteas
subject
degrad
replac
arg
ile
posit
render
proteas
resist
proteolysi
mutant
digest
conserv
undecapeptid
substrat
k
lm
k
cat
compar
valu
report
matur
proteas
contain
ctermin
histag
rel
activ
mutant
nearli
novel
peptidealdehyd
deriv
contain
sidechainprotect
ctermin
gln
effici
inhibit
catalyt
activ
mutant
result
indic
first
time
tetrapeptid
sequenc
enough
inhibitori
activ
peptidealdehyd
deriv
sever
acut
respiratori
syndrom
sar
lifethreaten
form
pneumonia
caus
new
coronaviru
sar
cov
although
primari
sar
epidem
affect
patient
leav
dead
eventu
control
effect
therapi
exist
viral
infect
sar
cov
positivesens
singlestrand
rna
viru
featur
largest
viral
rna
genom
known
date
genom
rna
produc
two
larg
protein
overlap
sequenc
polyprotein
kda
kda
autocatalyt
cleav
two
three
viral
proteas
yield
function
polypeptid
key
enzym
process
proteas
call
proteas
proteas
substrat
specif
similar
picornaviru
proteas
sar
proteas
cystein
proteas
chymotrypsin
fold
cleav
precursor
protein
mani
conserv
site
involv
conserv
gln
posit
small
amino
acid
ser
ala
gli
posit
vari
effici
proteas
exist
homodim
protom
activ
site
contain
cyshi
catalyt
dyad
fig
interact
ctermin
domainiii
protom
play
import
role
format
dimer
ntermin
end
one
protom
also
expect
interact
domainii
anoth
protom
fold
dimer
structur
although
studi
report
addit
sever
residu
cterminu
matur
proteas
significantli
affect
activ
kinet
properti
specif
matur
proteas
well
describ
due
function
import
viral
life
cycl
proteas
consid
attract
target
structurebas
design
drug
sar
sever
crystal
structur
sar
proteas
without
inhibitor
also
use
evalu
variou
type
inhibitor
proteas
inhibitor
contain
function
group
chloromethyl
keton
michael
acceptor
epoxid
react
irrevers
activesit
cystein
residu
studi
regard
revers
inhibitor
contain
aldehyd
group
function
group
report
cours
studi
sar
proteas
inhibitor
found
matur
proteas
could
process
two
fragment
devoid
catalyt
activ
report
high
level
express
escherichia
coli
purif
proteolysisresist
mutant
sar
proteas
kinet
character
mutant
reveal
remark
potenc
compar
matur
proteas
contain
ctermin
histag
potenc
make
possibl
evalu
newli
synthes
peptidealdehyd
inhibitor
quantit
convent
hplc
first
intend
obtain
matur
proteas
fusion
protein
contain
maltosebind
protein
mbp
flagtag
matur
proteas
mbphi
proteas
fig
correspond
plasmid
introduc
e
coli
desir
fusion
protein
obtain
major
product
total
cell
lysat
fig
lane
fusion
protein
easili
purifi
cobalt
affin
column
give
singl
major
band
sdspage
fig
lane
product
cleav
undecapeptid
substrat
hthrseralavalleuglnserglyphearglysnh
contain
p
p
cleavag
site
proteas
probabl
ntermin
fuse
larg
protein
digest
fusion
protein
enterokinas
ntermin
fragment
contain
mbp
detect
desir
protein
correspond
matur
proteas
hardli
detect
fig
lane
confirm
whether
protein
produc
ad
enterokinas
presenc
proteas
substrat
substrat
mix
fusion
protein
prior
addit
enterokinas
reaction
mixtur
substrat
complet
disappear
within
h
expect
fragment
peptid
clearli
identifi
malditofm
fig
glnoh
result
suggest
matur
proteas
temporarili
produc
digest
fusion
protein
enterokinas
tri
directli
express
proteas
contain
ctermin
histag
describ
previous
necessari
plasmid
construct
previou
plasmid
introduc
e
coli
desir
product
contain
matur
proteas
detect
major
product
fig
lane
experi
purif
cobalt
column
small
amount
product
detect
coomassi
stain
western
blot
use
antihistag
antibodi
fig
lane
fig
lane
immunostain
howev
decreas
intens
gradual
protein
emerg
placement
room
temperatur
fig
lane
overnight
incub
enterokinas
fig
lane
result
strongli
suggest
matur
proteas
suscept
degrad
proteolysi
identifi
probabl
cleavag
site
enterokinasebas
digest
fusion
protein
mbphi
proteas
fig
lane
care
examin
min
treatment
small
amount
enterokinas
desir
product
detect
faint
band
coomassi
stain
two
addit
band
also
detect
fig
lane
probabl
product
proteolysi
faint
band
disappear
prolong
treatment
min
fig
lane
newli
emerg
protein
seem
product
obtain
ctermin
histag
proteas
fig
lane
blot
protein
polyvinyliden
difluorid
pvdf
ntermin
sequenc
product
determin
glnthralaglnala
show
matur
proteas
cleav
site
ctermin
ahel
domainiii
matur
proteas
fig
homodimer
structur
matur
proteas
ahel
domain
expect
respons
orient
amino
terminu
one
monom
posit
interact
activ
site
monom
also
report
express
ntermin
catalyt
region
alon
yield
protein
reduc
catalyt
effici
thu
expect
biolog
role
ahel
domain
consist
find
proteolysi
site
rapidli
reduc
catalyt
effici
matur
proteas
obtain
activ
stabl
proteas
construct
mutant
substitut
ile
sitedirect
mutagenesi
substitut
select
remov
ionic
guanidin
group
without
remark
chang
steric
effect
arg
sidechain
similar
wildtyp
proteas
proteas
express
e
coli
fusion
protein
mutant
fusion
protein
obtain
major
product
easili
purifi
metal
affin
resin
fig
lane
enterokinas
treatment
desir
product
correspond
proteas
intens
stain
coomassi
proteolyt
product
detect
fig
lane
proteas
purifi
anion
exchang
chromatographi
ph
proteas
calcul
pi
flow
mbphi
flag
pi
absorb
resin
expect
fig
lane
mg
purifi
untag
protein
obtain
ml
bacteri
cultur
protein
correspond
ctermin
tag
also
directli
produc
major
product
fig
lane
singl
step
purif
metal
affin
resin
enough
obtain
highli
purifi
product
fig
lane
case
mg
purifi
ctermin
histag
protein
obtain
ml
cultur
purifi
mutant
protein
without
ctermin
tag
concentr
ultrafiltr
equal
volum
glycerol
ad
solut
store
without
loss
catalyt
activ
least
year
catalyt
activ
purifi
proteas
examin
use
three
differ
substrat
contain
p
p
cleavag
site
ntermin
selfcleavag
site
proteas
report
suitabl
substrat
canon
substrat
proteas
undecapeptid
contain
noncanon
p
p
cleavag
site
proteas
hexadecapeptid
contain
newli
found
proteolyt
site
substrat
differ
concentr
incub
mutant
proteas
cleavag
reaction
monitor
analyt
hplc
fig
initi
digest
rate
calcul
decreas
initi
amount
substrat
kinet
paramet
calcul
plot
v
summar
tabl
catalyt
abil
proteas
found
extrem
compar
previous
report
matur
proteas
contain
ctermin
tag
especi
k
cat
valu
min
matur
proteas
activ
mutant
rel
matur
proteas
nearli
addit
ctermin
histag
lower
rel
activ
owe
signific
decreas
k
cat
valu
result
suggest
addit
sequenc
nand
cterminu
matur
proteas
remark
affect
catalyt
activ
even
sever
addit
expect
matur
analysi
rel
effici
respect
compar
k
cat
k
rel
effici
vs
exactli
report
matur
proteas
rel
effici
nearli
report
cleavag
p
p
site
anoth
noncanon
cleavag
site
matur
proteas
suggest
matur
proteas
digest
precursor
protein
sar
cov
site
noncanon
cleavag
site
thu
examin
cleavag
matur
proteas
mutant
incub
ctermin
histag
matur
proteas
purifi
proteas
gave
degrad
product
deriv
proteas
fig
lane
result
suppos
proteas
digest
applic
mutant
proteas
size
matur
proteas
would
effect
acceler
develop
effici
inhibitor
sar
cov
proteas
suitabl
candid
reversibleinhibitor
select
peptidealdehyd
contain
sequenc
obtain
highli
homogen
deriv
effici
construct
aldehyd
group
reduct
correspond
weinreb
amid
prepar
solut
phase
synthesi
thu
start
fmocgln
trt
n
ome
peptid
chain
elong
conduct
use
combin
fmocdeprotect
diethylamin
coupl
reaction
use
bop
result
peptapeptid
weinreb
amid
acser
obu
alavalleugln
trt
n
ome
reduc
lialh
remain
sidechain
protect
group
remov
tfa
scheme
deprotect
product
purifi
hplc
yield
product
show
singl
peak
h
nmr
spectrum
product
howev
gave
aldehyd
signal
show
addit
methyl
signal
ppm
malditofm
also
show
higher
molecular
weight
expect
spectral
data
strongli
suggest
reduct
lithium
aluminum
hydrid
proceed
expect
lialh
attack
methoxi
group
instead
carbonyl
carbon
probabl
larg
steric
hindranc
trt
group
ctermin
gln
side
chain
gave
correspond
methylamid
deriv
scheme
avoid
undesir
reaction
synthes
peptidealdehyd
use
gln
deriv
use
sidechainprotect
gln
also
effect
prevent
equilibrium
desir
ctermin
aldehyd
correspond
hemiamin
form
unprotect
amid
gln
sidechain
start
fmocgluobu
dimethylamin
condens
sidechain
carboxyl
group
atertbutyl
ester
cleav
convert
weinreb
amid
subsequ
peptid
chain
elong
conduct
use
combin
fmocdeprotect
diethylamin
coupl
bop
scheme
result
hexapeptid
amid
reduc
lialh
deprotect
tfa
crude
product
purifi
hplc
give
singl
peak
analyt
hplc
malditofm
nmr
analys
gave
result
confirm
aldehyd
structur
peptid
aldehyd
contain
truncat
chain
similarli
synthes
correspond
intermedi
purifi
inhibitori
effect
newli
synthes
peptidealdehyd
inhibitor
assay
use
purifi
untag
proteas
substrat
peptid
incub
mutant
proteas
presenc
variou
concentr
peptidealdehyd
reaction
mixtur
analyz
hplc
fig
decreas
respect
concentr
inhibitor
sigmoid
doserespons
curv
obtain
fig
ic
valu
estim
sigmoid
curv
summar
tabl
tetrapeptid
sequenc
long
enough
inhibitori
activ
activ
increas
parallel
chain
length
hexapeptid
aldehyd
ic
lm
typic
cystein
proteas
inhibitor
show
nearli
inhibitori
activ
inhibit
mm
acvalleugln
cho
suggest
peptidealdehyd
deriv
would
promis
revers
sar
proteas
inhibitor
detail
structureact
studi
underway
neb
biolab
bacteri
express
vector
kindli
provid
dr
norio
yamamoto
prof
naoki
yamamoto
tokyo
medic
dental
univers
encod
protein
contain
fulllength
sar
cov
proteas
maltosebind
protein
sixhistidin
tag
flag
tag
mbphisflag
nterminu
design
releas
matur
proteas
free
nterminu
fusion
protein
enterokinas
treatment
purchas
peptid
institut
inc
osaka
minoh
japan
fmoc
amino
acid
deriv
purchas
form
watanab
chemic
inc
hiroshima
japan
analyt
prepar
hplc
perform
use
hitachi
elit
lachrom
system
od
nm
equip
nacalai
tesqu
cosmosil
mm
mm
revers
phase
column
product
elut
gradient
ch
cn
contain
tfa
aqueou
tfa
solut
h
mhz
c
mhz
nmr
spectra
record
bruker
chemic
shift
express
part
per
million
rel
tm
ppm
chcl
ppm
h
ppm
c
high
resolut
maldi
tofm
mass
spectra
obtain
bruker
autoflexii
optic
rotat
record
horiba
polarimet
sodium
line
fulllength
proteasecod
sequenc
amplifi
ccggctagcggttttaggaaaatggcattcc
contain
nhei
site
ccgctcgagttggaaggtaacaccagag
contain
xhoi
site
pcr
product
clone
directli
pgem
teasi
promega
produc
anoth
express
scheme
vector
made
insert
nheixhoi
fragment
correspond
proteasecod
fragment
nheixhoi
site
novagen
encod
protein
contain
fulllength
proteas
three
ntermin
amino
acid
metalas
two
ctermin
amino
acid
leuglu
plu
tag
affin
resinpurifi
fraction
lg
protein
ntermin
mbphisflagtag
proteas
incub
u
enterokinas
min
separ
sdspage
gel
transfer
pvdf
membran
coomassi
blue
stain
band
dissect
subject
edman
sequenc
determin
ntermin
analysi
perform
use
appli
biosystem
protein
sequenc
apro
life
scienc
institut
naruto
japan
acvalleunhch
ch
ch
con
ch
cho
mm
acalavalleunhch
ch
ch
con
ch
cho
lm
acseralavalleunhch
ch
ch
con
ch
cho
lm
acthrseralavalleunhch
ch
ch
con
ch
cho
lm
sitedirect
mutagenesi
perform
invers
pcr
method
describ
stemmer
morri
primer
use
gener
point
mutat
atctctcgtctccatacaaactgcac
aggctg
nucleotid
ital
mutat
atctctcgtctctgta
tgtcaacaaatggacc
pcr
perform
plasmid
templat
pcr
end
fulllength
linear
plasmid
digest
bsmbi
cgtctcnnnnn
leav
plasmid
compat
overhang
end
express
vector
construct
replac
short
sphistyi
fragment
short
nheixhoi
fragment
correspond
fragment
respect
sequenc
carri
confirm
presenc
desir
mutat
unintent
chang
purif
untag
l
proteas
metal
affin
resintr
fraction
ntermin
mbphisflagtag
proteas
mg
protein
incub
u
recombin
enterokinas
novagen
h
ml
buffer
contain
mm
trishcl
ph
mm
nacl
mm
cacl
enterokinas
remov
solut
use
ekaptur
agaros
novagen
buffer
chang
mm
bistri
ph
use
centricon
enterokinas
treat
fraction
appli
ml
bed
volum
deae
sepharos
ge
healthcar
equilibr
buffer
target
proteas
flow
though
sepharos
resin
mbphisflag
fragment
retain
resin
option
bound
protein
could
elut
buffer
contain
kcl
metal
affin
resintr
fraction
ctermin
histag
proteas
use
substrat
examin
degrad
incub
fraction
lg
protein
h
room
temperatur
u
enterokinas
lg
purifi
proteas
solut
separ
sdspage
gel
electroblot
onto
pvdf
membran
histag
proteas
cleav
product
visual
use
antihistag
monoclon
antibodi
novagen
biotinyl
antimous
igg
vector
amplifi
alkalin
phosphatas
immunblot
assay
kit
biorad
substrat
peptid
hthrseralavalleuglnserglyphearglysnh
hlysvalalathrvalglnserlysmetseraspnh
hglyprophevalaspargglnthralaglnalaalaglythraspthrnh
synthes
use
fmocbas
solidphas
peptid
synthesi
spp
start
rink
amid
resin
dimethoxyphenylfmoc
aminomethyl
phenoxi
resin
spp
achiev
combin
fmoc
deprotect
use
piperidinedmf
coupl
reaction
use
standard
diisopropylcarbodiimidehobt
protocol
peptid
purifi
prepar
hplc
cleavag
resin
treatment
tfa
thioanisol
proteolyt
activ
proteas
detect
cleavag
assay
use
analyt
hplc
peptid
mm
trishcl
buffer
ph
contain
mm
dtt
incub
proteas
cleavag
reaction
monitor
analyt
hplc
cosmosil
mm
ml
min
ch
cn
min
product
hydrolysi
identifi
malditof
ms
kinet
paramet
k
k
cat
determin
initi
rate
measur
hydrolysi
substrat
mmol
diea
ml
mmol
ad
fmocgluobu
g
mmol
ch
cl
ml
mixtur
stir
h
solvent
evapor
residu
dissolv
acoet
organ
phase
wash
citric
acid
nahco
brine
dri
mgso
solvent
evapor
residu
purifi
silicagel
column
chromatographi
use
chcl
meoh
desir
product
without
purif
treat
tfa
ml
presenc
anisol
ml
mmol
stir
h
tfa
evapor
residu
wash
hexan
dri
vacuo
residu
dissolv
dmf
ml
hn
ome
hcl
salt
g
mmol
bop
g
mmol
diea
ml
mmol
ad
mixtur
stir
h
solvent
evapor
residu
dissolv
acoet
organ
phase
wash
citric
acid
nahco
brine
dri
mgso
solvent
evapor
residu
purifi
silicagel
column
chromatographi
use
chcl
meoh
yield
desir
product
oil
yield
mixtur
stir
min
solvent
evapor
residu
dri
vacuo
residu
dissolv
ch
cl
ml
fmocleuoh
g
mmol
bop
g
mmol
diea
ml
mmol
ad
solut
mixtur
stir
h
solvent
evapor
residu
dissolv
acoet
organ
phase
wash
citric
acid
nahco
brine
dri
mgso
solvent
evapor
residu
purifi
silicagel
column
chromatographi
use
chcl
meoh
yield
desir
product
oil
yield
mmol
ch
cl
ch
cn
ml
treat
et
nh
ml
product
dmf
ml
ad
fmocalaoh
g
mmol
bop
g
mmol
diea
ml
mmol
mixtur
stir
h
crude
product
isol
purifi
silicagel
column
chromatographi
use
chcl
meoh
yield
desir
product
oil
yield
g
fmocser
bu
alavalleugln
n
ome
fmocalavalleugln
n
ome
g
mmol
ch
cl
ch
cn
ml
treat
et
nh
ml
product
dmf
ml
ad
fmocser
bu
oh
g
mmol
bop
g
mmol
diea
ml
mmol
mixtur
stir
h
crude
product
isol
purifi
silicagel
column
chromatographi
use
chcl
meoh
yield
desir
product
oil
yield
g
c
